FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for SIRTURO (bedaquiline fumarate) from Janssen Products, LP, likely updating the labeling or expanding indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• SIRTURO (bedaquiline fumarate)

Snippet

SUPPL AP for SIRTURO (BEDAQUILINE FUMARATE)